EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 130 filers reported holding EXELIXIS INC in Q3 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,959,465 | -12.9% | 621,249 | -8.0% | 0.00% | -25.0% |
Q1 2024 | $16,018,986 | -8.6% | 675,052 | -7.6% | 0.00% | 0.0% |
Q4 2023 | $17,533,500 | +6.9% | 730,867 | -2.6% | 0.00% | -33.3% |
Q3 2023 | $16,398,689 | +10.5% | 750,512 | -3.4% | 0.01% | +20.0% |
Q2 2023 | $14,843,349 | -5.4% | 776,732 | -3.9% | 0.01% | -16.7% |
Q1 2023 | $15,691,297 | +25.1% | 808,413 | +3.4% | 0.01% | +20.0% |
Q4 2022 | $12,542,301 | +3.7% | 781,939 | +1.4% | 0.01% | 0.0% |
Q3 2022 | $12,091,000 | -24.4% | 771,126 | +0.4% | 0.01% | -16.7% |
Q2 2022 | $15,993,000 | -0.2% | 768,161 | +8.6% | 0.01% | +20.0% |
Q1 2022 | $16,031,000 | +25.9% | 707,167 | +1.5% | 0.01% | +25.0% |
Q4 2021 | $12,735,000 | -15.1% | 696,663 | -1.9% | 0.00% | -20.0% |
Q3 2021 | $15,005,000 | +25.4% | 709,807 | +8.0% | 0.01% | +25.0% |
Q2 2021 | $11,970,000 | -26.2% | 656,933 | -8.5% | 0.00% | -33.3% |
Q1 2021 | $16,212,000 | +14.6% | 717,678 | +1.8% | 0.01% | 0.0% |
Q4 2020 | $14,149,000 | -20.2% | 704,992 | -2.8% | 0.01% | -25.0% |
Q3 2020 | $17,730,000 | +5.5% | 725,145 | +2.5% | 0.01% | 0.0% |
Q2 2020 | $16,802,000 | +121.1% | 707,765 | +60.4% | 0.01% | +100.0% |
Q1 2020 | $7,599,000 | -1.6% | 441,249 | +0.6% | 0.00% | 0.0% |
Q4 2019 | $7,726,000 | +9.3% | 438,498 | +9.8% | 0.00% | 0.0% |
Q3 2019 | $7,066,000 | -10.1% | 399,515 | +8.6% | 0.00% | 0.0% |
Q2 2019 | $7,860,000 | -5.4% | 367,788 | +5.3% | 0.00% | -20.0% |
Q1 2019 | $8,310,000 | +22.4% | 349,153 | +1.2% | 0.01% | 0.0% |
Q4 2018 | $6,790,000 | +17.3% | 345,180 | +5.7% | 0.01% | +25.0% |
Q3 2018 | $5,788,000 | -13.2% | 326,613 | +5.5% | 0.00% | -20.0% |
Q2 2018 | $6,665,000 | +90.5% | 309,695 | +96.1% | 0.01% | +66.7% |
Q1 2018 | $3,499,000 | -26.1% | 157,943 | +1.5% | 0.00% | 0.0% |
Q4 2017 | $4,732,000 | +55.8% | 155,663 | +24.2% | 0.00% | +50.0% |
Q3 2017 | $3,037,000 | +16.2% | 125,335 | +18.2% | 0.00% | 0.0% |
Q2 2017 | $2,613,000 | +42.5% | 106,075 | +25.1% | 0.00% | 0.0% |
Q1 2017 | $1,834,000 | +47.1% | 84,763 | +1.3% | 0.00% | +100.0% |
Q4 2016 | $1,247,000 | +94.2% | 83,685 | +63.4% | 0.00% | 0.0% |
Q3 2016 | $642,000 | +101.3% | 51,219 | +24.9% | 0.00% | – |
Q2 2016 | $319,000 | +134.6% | 40,997 | +22.4% | 0.00% | – |
Q1 2016 | $136,000 | -20.5% | 33,497 | +11.4% | 0.00% | – |
Q4 2015 | $171,000 | -1.2% | 30,057 | 0.0% | 0.00% | – |
Q3 2015 | $173,000 | +60.2% | 30,057 | 0.0% | 0.00% | – |
Q2 2015 | $108,000 | +35.0% | 30,057 | 0.0% | 0.00% | – |
Q1 2015 | $80,000 | +95.1% | 30,057 | 0.0% | 0.00% | – |
Q4 2014 | $41,000 | -12.8% | 30,057 | 0.0% | 0.00% | – |
Q3 2014 | $47,000 | – | 30,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |